AIM ImmunoTech Inc.
AIM
$0.119
-$0.001-0.83%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -3.70M | -1.84M | -5.82M | -12.58M | -7.82M |
| Total Depreciation and Amortization | 63.00K | 61.00K | 58.00K | 58.00K | 53.00K |
| Total Amortization of Deferred Charges | -38.00K | 197.00K | 73.00K | -- | -- |
| Total Other Non-Cash Items | 180.00K | 840.00K | 105.00K | 678.00K | 159.00K |
| Change in Net Operating Assets | 385.00K | -2.27M | 766.00K | 2.08M | 1.93M |
| Cash from Operations | -3.11M | -3.01M | -4.82M | -9.76M | -5.67M |
| Capital Expenditure | -18.00K | -- | -- | 10.00K | -10.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | 47.00K | -35.00K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 352.00K | 826.00K | -158.00K | -271.00K | -291.00K |
| Cash from Investing | 334.00K | 826.00K | -158.00K | -214.00K | -336.00K |
| Total Debt Issued | 133.00K | -133.00K | 2.50M | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 4.00K | 527.00K | 329.00K | 147.00K | 233.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | 2.05M | -- | -- | -- |
| Cash from Financing | 137.00K | 2.44M | 2.83M | 147.00K | 233.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -2.64M | 259.00K | -2.14M | -9.83M | -5.77M |
